Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    23748507 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly;   Drug: metformin;   Drug: sitagliptin;   Drug: pioglitazone
2 Completed
Has Results
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly;   Drug: sitagliptin;   Drug: pioglitazone;   Drug: placebo tablet;   Drug: placebo once weekly

Study has passed its completion date and status has not been verified in more than two years.